Demonstrated that specific mutations affect activation profiles
Revealed potential for targeted therapies based on activation pathways
Abstract
Endometrial carcinoma (EC) is one of the most prevalent gynaecological malignancies found in women. About 10-12% of EC is caused due to mutations in Fibroblast Growth Factor Receptor 2 (FGFR2)....
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Allosteric Activation of FGFR2 Kinase in Endometrial Cancer: Insights from Gaussian Accelerated Molecular Dynamics and Markov State Model | Synapse